An official website of the United States government
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2006
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alaska | 129 | 52.1 | 7.3 | (37.8 – 66.4) | 131 | 53.4 | 6.9 | (39.9 – 66.9) |
| Arizona | 154 | 52.3 | 7.7 | (37.2 – 67.4) | 162 | 49.0 | 7.5 | (34.3 – 63.7) |
| California | 245 | 54.3 | 4.2 | (46.1 – 62.5) | 267 | 52.3 | 4.1 | (44.3 – 60.3) |
| Colorado | 275 | 60.2 | 3.8 | (52.8 – 67.6) | 293 | 58.2 | 3.7 | (50.9 – 65.5) |
| Connecticut | 324 | 49.9 | 4.2 | (41.7 – 58.1) | 357 | 45.6 | 3.9 | (38.0 – 53.2) |
| District of Columbia | 130 | 51.8 | 7.3 | (37.5 – 66.1) | 142 | 50.4 | 6.8 | (37.1 – 63.7) |
| Georgia | 257 | 44.9 | 5.0 | (35.1 – 54.7) | 273 | 44.7 | 4.9 | (35.1 – 54.3) |
| Hawaii | 221 | 48.7 | 4.6 | (39.7 – 57.7) | 247 | 50.6 | 4.4 | (42.0 – 59.2) |
| Indiana | 319 | 56.2 | 3.6 | (49.1 – 63.3) | 338 | 54.9 | 3.4 | (48.2 – 61.6) |
| Iowa | 180 | 53.3 | 4.2 | (45.1 – 61.5) | 193 | 50.2 | 4.1 | (42.2 – 58.2) |
| Kansas | 394 | 53.8 | 3.4 | (47.1 – 60.5) | 400 | 53.7 | 3.4 | (47.0 – 60.4) |
| Maine | 182 | 60.1 | 4.5 | (51.3 – 68.9) | 195 | 58.6 | 4.4 | (50.0 – 67.2) |
| Maryland | 292 | 40.9 | 4.2 | (32.7 – 49.1) | 338 | 38.7 | 3.9 | (31.1 – 46.3) |
| Massachusetts | 270 | 54.7 | 4.9 | (45.1 – 64.3) | 288 | 49.1 | 5.0 | (39.3 – 58.9) |
| Michigan | 321 | 51.5 | 3.6 | (44.4 – 58.6) | 347 | 47.3 | 3.5 | (40.4 – 54.2) |
| Missouri | 257 | 48.8 | 5.5 | (38.0 – 59.6) | 271 | 48.5 | 5.4 | (37.9 – 59.1) |
| Montana | 205 | 43.2 | 5.1 | (33.2 – 53.2) | 215 | 40.8 | 4.8 | (31.4 – 50.2) |
| Nebraska | 229 | 60.9 | 6.0 | (49.1 – 72.7) | 244 | 55.9 | 6.0 | (44.1 – 67.7) |
| New Hampshire | 236 | 51.2 | 4.2 | (43.0 – 59.4) | 264 | 44.5 | 4.1 | (36.5 – 52.5) |
| New York | 276 | 54.8 | 4.1 | (46.8 – 62.8) | 297 | 50.2 | 4.0 | (42.4 – 58.0) |
| Oregon | 294 | 52.7 | 4.5 | (43.9 – 61.5) | 327 | 47.0 | 4.4 | (38.4 – 55.6) |
| Texas | 230 | 57.7 | 5.8 | (46.3 – 69.1) | 253 | 48.7 | 7.0 | (35.0 – 62.4) |
| Vermont | 417 | 53.3 | 3.3 | (46.8 – 59.8) | 437 | 53.9 | 3.1 | (47.8 – 60.0) |
| Washington | 1,467 | 52.4 | 2.2 | (48.1 – 56.7) | 1,606 | 49.3 | 2.0 | (45.4 – 53.2) |
| Wisconsin | 221 | 53.5 | 5.5 | (42.7 – 64.3) | 225 | 53.1 | 5.5 | (42.3 – 63.9) |
| 25 areas total | 7,525 | 53.3 | 1.4 | (50.6 – 56.0) | 8,110 | 49.9 | 1.5 | (47.0 – 52.8) |
| Median | 52.7 | 50.2 | ||||||
| Range | 40.9-60.9 | 38.7-58.6 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size excludes “DK/Refused”
§ Standard error
† Confidence interval